All posts by admin

10Oct/13

Gilead halts leukaemia study on positive results – PMLiVE

October 10, 2013Monoclonal Anti-CD20 Antibodiesadmin

Gilead halts leukaemia study on positive results
PMLiVE
The trial – known as Study 116 – is comparing idelalisib plus Roche/Biogen Idec’s Rituxan (rituximab) to rituximab alone in patients unsuitable for treatment with conventional chemotherapy. At an interim analysis, the combination was found to have a …
Gilead Stops Cancer Drug Trial Early On Positive ResultsNASDAQ
UPDATE: Gilead to Stop Phase 3 Study 116 of Idelalisib in Chronic Lymphocytic …Benzinga
Gilead stops leukaemia drug trial earlyPharmaTimes
MarketWatch
all 21 news articles »

10Oct/13

Alethia Biotherapeutics obtains US patent for use of anti-Siglec-15 antibodies – Pharmaceutical Business Review

October 10, 2013Antibodiesadmin

Alethia Biotherapeutics obtains US patent for use of anti-Siglec-15 antibodies
Pharmaceutical Business Review
The patent entitled ‘Polynucleotides and Polypeptide Sequences involved in the Process of Bone Remodeling’, provides broad protection for antibodies that target Siglec-15 and also having osteoclast differentiation or bone resorption inhibitory activity.

10Oct/13

Glenmark files lawsuit in US court for Hydrocortisone Butyrate cream – Myiris.com

October 10, 2013Immunosuppressive Drugsadmin

LivemintGlenmark files lawsuit in US court for Hydrocortisone Butyrate creamMyiris.comGlenmark Generics Inc, USA the subsidiary of Glenmark Generics has filed a lawsuit in the court of chancery of the state of Delaware against Astellas Pharma Europe B….

10Oct/13

Gilead stops leukaemia drug trial early – PharmaTimes

October 10, 2013Monoclonal Anti-CD20 Antibodiesadmin

Gilead stops leukaemia drug trial early
PharmaTimes
The safety profile of the drug was also found to be “acceptable and consistent with prior experience” when combing it with rituximab in previously treated CLL. Norbert Bischofberger, Gilead’s R&D chief, said the firm is pleased that idelalisib has …

10Oct/13

Heptares' StaR platform offers breakthrough solution to challenge associated … – News-Medical.net

October 10, 2013Antibodiesadmin

Heptares’ StaR platform offers breakthrough solution to challenge associated …
News-Medical.net
Heptares’ StaR platform offers a breakthrough solution to the main challenge associated with making antibodies against GPCRs: producing purified, properly folded and functional protein when removed from the cell membrane for use as an antigen.
Heptares Delivers First Stabilised GPCR (StaR®) to MorphoSys for Antibody …PR Newswire (press release)

all 2 news articles »

10Oct/13

Canton-Potsdam Hospital receives grant for heart failure care – WatertownDailyTimes.com

October 10, 2013Organ Failureadmin

Canton-Potsdam Hospital receives grant for heart failure care
WatertownDailyTimes.com
POTSDAM — Canton-Potsdam Hospital has received the last installment of a three-year, $40,000 grant from Excellus BlueCross/BlueShield to help patients with congestive heart failure. The money is used to provide home care for patients after they leave …

10Oct/13

Research and Markets: Onartuzumab (Non-Small Cell Lung Cancer) – Forecast … – The Herald | HeraldOnline.com

October 10, 2013Lungadmin

Research and Markets: Onartuzumab (Non-Small Cell Lung Cancer) – Forecast …The Herald | HeraldOnline.comSales forecast for Onartuzumab for the top nine countries from 2012 to 2022. – Sales information covered for the US, France, Germany, Italy, Spain…

10Oct/13

5 Things to Know for Your New Day – Thursday, October 10 – CNN (blog)

October 10, 2013Organ Donor, Organs, Other Transplantationadmin

5 Things to Know for Your New Day – Thursday, October 10
CNN (blog)
Three children from the Spirit Lake Tribe will not reconcile with their mom this week because the Bureau of Indian Affairs social worker is on furlough, according to this report. The government paid $47,000 for a … There’s no money to help the …

and more »

10Oct/13

Heptares Delivers First Stabilised GPCR (StaR®) to MorphoSys for Antibody … – HispanicBusiness.com

October 10, 2013Antibodiesadmin

Heptares Delivers First Stabilised GPCR (StaR®) to MorphoSys for Antibody …
HispanicBusiness.com
The milestone is based on the generation of a stabilised (StaR(R)) form of the first GPCR target selected by MorphoSys, a key step that will enable its use as an antigen against which novel antibodies can be produced. Heptares will receive an …

and more »

10Oct/13

Photos: Srihari's Body Brought To Hyderabad; Celebs Pay Last Respect – Oneindia Entertainment

October 10, 2013Liveradmin

Photos: Srihari’s Body Brought To Hyderabad; Celebs Pay Last Respect
Oneindia Entertainment
The mortal remains of Telugu actor Srihari, who died due to liver-related problems at the Leelavathi hospital in Mumbai at 5.35 pm on Wednesday, were brought to his residence in Hyderabad this morning. Many Telugu celebrities, who were shocked by his …

Archives